niquitin pepermunt 4 mg zuigtabletten
omega pharma nederland b.v. kralingseweg 201 3062 ce rotterdam - nicotineresinaat 20 mg/stuk samenstelling overeenkomend met ; nicotine 4 mg/stuk - zuigtablet - aspartaam (e 951) ; kaliumwaterstofcarbonaat (e 501 (ii)) ; magnesiumstearaat (e 470b) ; mannitol (d-) (e 421) ; natriumalginaat (e 401) ; natriumcarbonaat 0-water (e 500 (i)) ; pepermuntpoeder smaakstof ; polycarbofil calcium ; xanthaangom (e 415), - nicotine
humuline 30/70 100 ie/ml - 100 iu/ml inj. susp. s.c./i.m. flac.
eli lilly benelux sa-nv - humane insuline 100 ie/ml - suspensie voor injectie - insulin (human)
humuline nph 100 ie/ml - 100 iu/ml inj. susp. s.c./i.m. flac.
eli lilly benelux sa-nv - humane insuline 100 ie/ml - suspensie voor injectie - insulin (human)
humuline regular 100 ie/ml - 100 iu/ml inj. opl. s.c./i.v./i.m. flac.
eli lilly benelux sa-nv - humane insuline 100 ie/ml - oplossing voor injectie - insulin (human)
eucreas
novartis europharm limited - vildagliptin, metformine hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
galvus
novartis europharm limited - vildagliptine - diabetes mellitus, type 2 - geneesmiddelen die worden gebruikt bij diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformine hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 en 5. 1 voor de beschikbare gegevens over verschillende combinaties).
jalra
novartis europharm limited - vildagliptine - diabetes mellitus, type 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 en 5. 1 voor de beschikbare gegevens over verschillende combinaties).
zomarist
novartis europharm limited - vildagliptin, metformine hydrochloride - diabetes mellitus, type 2 - geneesmiddelen die worden gebruikt bij diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.
xiliarx
novartis europharm limited - vildagliptine - diabetes mellitus, type 2 - geneesmiddelen die worden gebruikt bij diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 en 5. 1 voor de beschikbare gegevens over verschillende combinaties).